View More View Less
  • 1 University of Concepción Department of Pharmacy, Faculty of Pharmacy P.O. Box 237 Concepción Chile
  • | 2 University of Concepción Department of Bromatology, Nutrition and Dietetic, Faculty of Pharmacy P.O. Box 237 Concepción Chile
Restricted access

A high-performance thin-layer chromatography (HPTLC) method for the quantification of propranolol in human serum is developed and validated. The method includes a liquid-liquid extraction of the analyte from the matrix using n-heptane-isoamyl alcohol (98.5:1.5, v/v) as the extraction solvent and verapamil as the internal standard.The HPTLC method employed precoated silica gel F254 HPTLC plates (10 cm × 10 cm and 10 cm × 20 cm; layer thickness 0.2 mm) prewashed with methanol, and a mobile phase comprising chloroform-methanol-ammonia (9:1:0.04, v/v/v). The developing solvent was run up to 80 mm in a vertical CAMAG chamber previously saturated with the solvent mixture for 20 min. Densitometric detection was done at λ = 290 nm. The method was linear between 5 and 100 ng/band, corresponding to 0.01 and 0.20 ng μL−1 of propranolol in human serum after the extraction process and applying 50 μL to the chromatographic plates (correlation coefficient = 0.998). The %RSD (absolute value of the coefficient of variation) of intra-assay and inter-assay precision was in the range 1.84–2.85% (n = 3) and 3.52–3.95% (n = 9), respectively. The limit of detection and limit of quantitation were found to be 3.15 and 4.02 ng/band, respectively. The method proved to be accurate, with a recovery between 96.35% and 98.82%, with an RSD not higher than 4.17%, and was selective for the active substance tested, its major metabolite, and the internal standard. This method was successfully applied to quantify propranolol in patient serum samples. Therefore, the method is useful for the quantitative determination of propranolol in human serum.

  • G.K. McEvoy (ed.) AHFS Drug Information, American Society of Health-System Pharmacists, Bethesda, 2009.

    '', in AHFS Drug Information , (2009 ) -.

  • J. Oates, in: H. Hardman, L. Limbird (eds.) Las Bases Farmacológicas de la Terapéutic, Mc Graw-Hill, México, 2003.

    Oates J. , '', in Las Bases Farmacológicas de la Terapéutic , (2003 ) -.

  • S. Sweetman, Martindale, GuÍa Completa de Consulta Farmacoterapéutica, 2nd edn., Pharma Editores S.L., Barcelona, 2005.

    Sweetman S. , '', in Martindale, GuÍa Completa de Consulta Farmacoterapéutica , (2005 ) -.

  • B.L. Van Wijk, O.H. Klungel, E.R. Heerdink, A. de Boer, Pharmacoepidemiol. Drug Saf. 15 (2006) 587–593.

    Boer A. , '' (2006 ) 15 Pharmacoepidemiol. Drug Saf. : 587 -593.

  • B.L. Van Wijk, O.H. Klunge, E.R. Heerdink, A. de Boer, J. Hypertens. 23 (2005) 2101–2107.

    Boer A. , '' (2005 ) 23 J. Hypertens. : 2101 -2107.

  • N.S. Breekveldt-Postma, F.J. Penning-van Beest, S.J. Siiskonen, H. Falve, G. Vincze, O.H. Klunge, R.M. Herings, Curr. Med. Res. Opin. 24 (2008) 121–127.

    Herings R.M. , '' (2008 ) 24 Curr. Med. Res. Opin. : 121 -127.

  • N. Fitz-Simon, K. Bennett, J. Feely, Ther. Clin. Risk Manag. 1 (2005) 93–106.

    Feely J. , '' (2005 ) 1 Ther. Clin. Risk Manag. : 93 -106.

  • B. Bokhour, D. Berlowitz, J. Long, N. Kressin, J. Gen. Intern. Med. 21 (2006) 577–583.

    Kressin N. , '' (2006 ) 21 J. Gen. Intern. Med. : 577 -583.

  • K. Johnell, L. Rastam, T. Lithman, J. Sundquist, J. Merlo, BMC Public Health 5 (2005) 17.

    Merlo J. , '' (2005 ) 5 BMC Public Health : 17 -.

  • C. Dolder, K. Furtek, L. Lacro, D. Jeste, Psychosomatics 46 (2005) 135–141.

    Jeste D. , '' (2005 ) 46 Psychosomatics : 135 -141.

  • L. Osterberg, T. Blaschke, NEJM 353 (2005) 487–497.

    Blaschke T. , '' (2005 ) 353 NEJM : 487 -497.

  • C. Sanches, F. Gala, A. Silva, M.J. Carmona, J. Otavio, S. Cavani, J. Santos, Clinics 62 (2007) 215–224.

    Santos J. , '' (2007 ) 62 Clinics : 215 -224.

  • J. Zhang, L. Ding, A. Wen, F. Wu, L. Sun, L. Yang, AJPS 4 (2009) 169–177.

    Yang L. , '' (2009 ) 4 AJPS : 169 -177.

  • G. Nygard, W. Shelver, S.K. Wahba Khalil, J. Pharm. Sci. 68 (2006) 379–381.

    Wahba Khalil S.K. , '' (2006 ) 68 J. Pharm. Sci. : 379 -381.

  • P. Partani, Y. Mochave, S. Gourde, A. Khurp, T. Monit, J. Pharm. Biomed. Anal. 50 (2009) 976–996.

    Monit T. , '' (2009 ) 50 J. Pharm. Biomed. Anal. : 976 -996.

  • P. Valderrama, R.J. Poppi, Anal. Chim. Acta 651 (2009) 31–35.

    Poppi R.J. , '' (2009 ) 651 Anal. Chim. Acta : 31 -35.

  • J. Collins, D. Arrtigan, Anal. Chem. 81 (2009) 2344–2349.

    Arrtigan D. , '' (2009 ) 81 Anal. Chem. : 2344 -2349.

  • I. Wilson, Ther. Drug Monit. 18 (1996) 484–492.

    Wilson I. , '' (1996 ) 18 Ther. Drug Monit. : 484 -492.

  • S. Mennickent, A. Sobarzo, M. Vega, C.G. Godoy, M. de Diego, J. Sep. Sci. 30 (2007) 2167–2172.

    Diego M. , '' (2007 ) 30 J. Sep. Sci. : 2167 -2172.

  • S. Mennickent, R. Fierro, M. Vega, M. de Diego, C.G. Godoy, J. Sep. Sci. 32 (2009) 1454–1458.

    Godoy C.G. , '' (2009 ) 32 J. Sep. Sci. : 1454 -1458.

  • S. Mennickent, A. Sobrazo, M. Vega, M. de Diego, C.G. Godoy, P. Rioseco, L. Saavedra, Int. J. Psych. Clin. Pract. 14 (2010) 41–46.

    Saavedra L. , '' (2010 ) 14 Int. J. Psych. Clin. Pract. : 41 -46.

  • S. Mennickent, L. Pino, M. Vega, C.G. Godoy, M. de Diego, J. Sep. Sci. 30 (2007) 772–777.

    Diego M. , '' (2007 ) 30 J. Sep. Sci. : 772 -777.

  • S. Mennickent, L. Pino, M. Vega, M. de Diego, J. Sep. Sci. 31 (2007) 201–206.

    Diego M. , '' (2007 ) 31 J. Sep. Sci. : 201 -206.

  • S. Mennickent, M. Nai, M. Vega, M. de Diego, J. Sep. Sci. 30 (2007) 1893–1898.

    Diego M. , '' (2007 ) 30 J. Sep. Sci. : 1893 -1898.

  • S. Mennickent, J. Contreras, C. Reyes, M. Vega, M. de Diego, J. Planar Chromatogr. 23 (2010) 1–13.

    Diego M. , '' (2010 ) 23 J. Planar Chromatogr. : 1 -13.

  • Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Rockville, MD, 2001.

    '', in Bioanalytical Method Validation , (2001 ) -.

  • G. Shabir, J. Chromatogr. A 987 (2003) 57–66.

    Shabir G. , '' (2003 ) 987 J. Chromatogr. A : 57 -66.

  • O. Quattrochi, S. Abelaira, R. Labra, Introducción a la HPLC. Aplicación y Práctica, Artes Gráficas Farro S.A, Buenos Aires, 1992.

    Labra R. , '', in Introducción a la HPLC. Aplicación y Práctica , (1992 ) -.

  • W. Daniel, Bioestadística. Base para el Análisis de las Ciencias de la Salud, Uteha Noriega Editores, México, 1996.

    Daniel W. , '', in Bioestadística , (1996 ) -.

  • The United States Pharmacopeia, U.S. Pharmacopeial Convection Inc., Rockville, MD, 2005.

For Submission Guideline click HERE

Manuscript Submission: JPC Manuscript Submission

Senior editors

Editor(s)-in-Chief: B. Spangenberg

Managing Editor: Kakuk Ágnes

Editorial Board

  • T.H. Dzido (Lublin, Poland)
  • Á. M. Móricz (Budapest, Hungary)
  • C.F. Poole (Detroit, MI, USA)
  • E. Reich (Muttenz, Switzerland)
  • B. Renger (Radolfzell, Germany)
  • I. Vovk (Ljubljana, Slovenia)

 

Advisory Board

  • E. BODOKI (Cluj-Napoca, Romania)
  • U. A. TH. BRINKMAN (Amsterdam, The Netherlands)
  • I. CHOMA (Lublin, Poland)
  • V. COMAN (Cluj-Napoca, Romania)
  • W. DAMMERTZ (Kressbronn, Germany)
  • K. FERENCZI-FODOR (Budapest, Hungary)
  • G. INDRAYANTO (Surabaya, Indonesia)
  • R. E. KAISER (Bad Dürkheim, Germany)
  • I. KLEBOVICH (Budapest, Hungary)
  • T. KOWALSKA (Katowice, Poland)
  • L. LEPRI (Florence, Italy)
  • E. MINCSOVICS (Budapest, Hungary)
  • D. NUROK (Indianapolis, IN, USA)
  • B. RENGER (Radolfzell, Germany)
  • J. K. RÓŻYŁO (Lublin, Poland)
  • J. SHERMA (Easton, PA, USA)
  • M. WAKSMUNDZKA-HAJNOS (Lublin, Poland)
  • D. WEDGE (Mississippi, USA)

A. Kakuk - Managing Editor, Akadémiai Kiadó
Address: P.O. Box 245. H-1519 Budapest, Hungary
Fax: +36 1 464 82 95
E-mail: jpc@akkrt.hu

Indexing and Abstracting Services:

  • Science Citation Index
  • Sci Search Research Alert
  • Chemistry Citation Index and Current Content/Physical
  • Chemical and Earth Sciences

 

Journal of Planar Chromatography - Modern TLC
Language English
Size A4
Year of
Foundation
1988
Volumes
per Year
1
Issues
per Year
6
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0933-4173 (Print)
ISSN 1789-0993 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 1 0 0
Jun 2021 9 0 0
Jul 2021 2 0 0
Aug 2021 4 0 0
Sep 2021 0 0 0
Oct 2021 0 0 0
Nov 2021 0 0 0